Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Peter Fischer

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|May 25, 2006
Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomasSusanne Haas, Christiane Pierl, Volker Harth, et al.
The Lancet. Oncology|May 1, 2007
Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancerJuan José Hernando, Tjoung-Won Park, Hans-Peter Fischer, et al.
Plos One|March 21, 2014
ATZ11 recognizes not only Z-α1-antitrypsin-polymers and complexed forms of non-Z-α1-antitrypsin but also the von Willebrand factorDiane Goltz, Kanishka Hittetiya, Hamideh Yadegari, et al.
European Radiology|June 27, 2023
MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinomaPatrick Arthur Kupczyk, Darius Kurt, Christoph Endler, et al.
The Journal of Pathology|October 11, 2005
Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 stainingElisabeth Mangold, Constanze Pagenstecher, Waltraut Friedl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 31, 2014
Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading systemSamer Ezziddin, Linda Adler, Amir Sabet, et al.
European Journal of Epidemiology|September 10, 2005
Factors modifying the association between hormone-replacement therapy and breast cancer riskBeate Pesch, Yon Ko, Hiltrud Brauch, et al.
Plos One|July 23, 2011
Transgenic overexpression of Tcfap2c/AP-2gamma results in liver failure and intestinal dysplasiaDaniel Holl, Peter Kuckenberg, Tatiana Woynecki, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 6, 2010
Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosisMartin Hennenberg, Jonel Trebicka, Zaki Kohistani, et al.
Human Pathology|July 27, 2007
Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinomaJan P Berg, Qi Zhou, Kai Breuhahn, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|May 25, 2006
Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomasSusanne Haas, Christiane Pierl, Volker Harth, et al.
The Lancet. Oncology|May 1, 2007
Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancerJuan José Hernando, Tjoung-Won Park, Hans-Peter Fischer, et al.
Plos One|March 21, 2014
ATZ11 recognizes not only Z-α1-antitrypsin-polymers and complexed forms of non-Z-α1-antitrypsin but also the von Willebrand factorDiane Goltz, Kanishka Hittetiya, Hamideh Yadegari, et al.
European Radiology|June 27, 2023
MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinomaPatrick Arthur Kupczyk, Darius Kurt, Christoph Endler, et al.
The Journal of Pathology|October 11, 2005
Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 stainingElisabeth Mangold, Constanze Pagenstecher, Waltraut Friedl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 31, 2014
Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading systemSamer Ezziddin, Linda Adler, Amir Sabet, et al.
European Journal of Epidemiology|September 10, 2005
Factors modifying the association between hormone-replacement therapy and breast cancer riskBeate Pesch, Yon Ko, Hiltrud Brauch, et al.
Plos One|July 23, 2011
Transgenic overexpression of Tcfap2c/AP-2gamma results in liver failure and intestinal dysplasiaDaniel Holl, Peter Kuckenberg, Tatiana Woynecki, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 6, 2010
Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosisMartin Hennenberg, Jonel Trebicka, Zaki Kohistani, et al.
Human Pathology|July 27, 2007
Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinomaJan P Berg, Qi Zhou, Kai Breuhahn, et al.
Pageof 10